Aurinia Pharmaceuticals Inc. (AUPH): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

138.70M
Year ended 2025-12-31
-0.8%
3-year compound annual growth
+3.2%
5-year compound annual growth
146.19M2020-12-31: 118.47M2021-12-31: 129.37M2022-12-31: 141.91M2023-12-31: 143.24M2024-12-31: 146.19M2025-12-31: 138.70M138.70M
2020-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31138.70M-5.1%2026-02-26, From 2025-01-01
2024-12-31146.19M+2.1%2026-02-26, From 2024-01-01
2023-12-31143.24M+0.9%2026-02-26, From 2023-01-01
2022-12-31141.91M+9.7%2025-02-27, From 2022-01-01
2021-12-31129.37M+9.2%2024-02-15, From 2021-01-01
2020-12-31118.47Mn/a2023-02-28, From 2020-01-01